These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29695613)

  • 21. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
    Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
    Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
    Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
    Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E; Wu Z; Shon JC; Liu KH
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
    Chen C; Wei X; Rao X; Wu J; Yang S; Chen F; Ma D; Zhou J; Dackor RT; Zeldin DC; Wang DW
    J Pharmacol Exp Ther; 2011 Feb; 336(2):344-55. PubMed ID: 21030485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
    Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
    Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Wang Y; Wei X; Xiao X; Hui R; Card JW; Carey MA; Wang DW; Zeldin DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):522-32. PubMed ID: 15840765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
    Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
    Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
    Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
    Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthracycline derivatives inhibit cardiac CYP2J2.
    Kim JS; Arango AS; Shah S; Arnold WR; Tajkhorshid E; Das A
    J Inorg Biochem; 2022 Apr; 229():111722. PubMed ID: 35078036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
    Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
    Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
    Knickle LC; Bend JR
    Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2.
    Ning J; Liu T; Dong P; Wang W; Ge G; Wang B; Yu Z; Shi L; Tian X; Huo X; Feng L; Wang C; Sun C; Cui J; James TD; Ma X
    J Am Chem Soc; 2019 Jan; 141(2):1126-1134. PubMed ID: 30525564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase.
    Arnold WR; Baylon JL; Tajkhorshid E; Das A
    Biochemistry; 2016 Dec; 55(50):6969-6980. PubMed ID: 27992998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2.
    Kojima A; Nadai M; Murayama N; Yamazaki H; Katoh M
    Xenobiotica; 2022 Jul; 52(7):669-675. PubMed ID: 36251932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate binding to cytochrome P450-2J2 in Nanodiscs detected by nanoplasmonic Lycurgus cup arrays.
    Plucinski L; Ranjan Gartia M; Arnold WR; Ameen A; Chang TW; Hsiao A; Logan Liu G; Das A
    Biosens Bioelectron; 2016 Jan; 75():337-46. PubMed ID: 26334592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
    Spiecker M; Liao J
    Trends Cardiovasc Med; 2006 Aug; 16(6):204-8. PubMed ID: 16839864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.